Radioligand Therapy (RLT) Market Growth Drivers, Challenges and Opportunities
The Radioligand Therapy (RLT) Market is expanding across major healthcare regions as precision oncology and radiopharmaceutical technologies become more widely adopted. North America currently represents the leading regional market. In 2024, the region accounted for more than 45% of global RLT revenue, supported by advanced healthcare infrastructure, cancer treatment capabilities, research...
0 Comments 0 Shares 54 Views 0 Reviews